Boston University Professor Ioannis Paschalidis Inducted Into Prestigious AIMBE College of Fellows for 2026

Boston University Professor Ioannis Paschalidis joins the top 2% of medical engineers for his pioneering AI research in healthcare and medicine.

By: AXL Media

Published: Apr 14, 2026, 7:29 AM EDT

Source: Information for this report was sourced from EurekAlert

The Highest Echelon of Biological Engineering

The American Institute for Medical and Biological Engineering, known as AIMBE, formally inducted Ioannis Paschalidis into its 2026 College of Fellows on April 13, 2026. This membership is reserved for the top two percent of researchers in the field, representing a peer-elected honor for those who have significantly altered the landscape of medicine and healthcare. According to the institute, the induction ceremony took place during the AIMBE Annual Event held in Arlington, Virginia. Paschalidis joins a distinguished group that includes Nobel laureates and recipients of the Presidential Medal of Science and Technology.

A Multi-Disciplinary Leader at Boston University

Paschalidis serves as a distinguished professor across several departments at Boston University, including electrical and computer engineering, systems engineering, and biomedical engineering. He is also the director of the Rafik B. Hariri Institute for Computing and Computational Science and Engineering, which is the university's largest research hub for multidisciplinary AI research. His career, marked by over 10,000 citations, has focused on a convergent research philosophy that blends data science with clinical practice to address complex societal issues.

Predictive Analytics and Disease Surveillance

A significant portion of the research conducted by Paschalidis involves using electronic health records to identify early warning signals for major health events. His work has demonstrated the ability to predict heart-related hospitalizations nearly a year in advance by applying supervised learning to longitudinal patient data. Furthermore, he has developed a robust machine learning framework that analyzes speech patterns to identify early markers of cognitive decline. This approach has shown efficacy in predicting the progression of Alzheimer’s disease years before a clinical diagnosis is typically made.